Sandoz is a global pharmaceutical manufacturer focused on generic medicines and biosimilars. The company is a leading producer of anti-infectives—particularly penicillins—and supplies active pharmaceutical ingredients (APIs) and finished-dose formulations to healthcare systems worldwide. Its operations span chemical synthesis, industrial fermentation, and biopharmaceutical manufacturing, with a strong presence in Europe.
Sandoz maintains a vertically integrated penicillin network in Europe and invests in advanced capabilities for biosimilar development and analytical characterization. Key sites include antibiotics production in Kundl, Austria; biosimilar R&D in Holzkirchen, Germany; and expanding biologics and bioproduction activities in Slovenia. The company emphasizes secure, regional supply chains for critical medicines and manufactures to international GMP and quality standards, making it a significant player at the intersection of the chemical and life sciences industries.